Panel Discussion: Current advances in Pharma Analytical Development: Trends and Technologies

Panelists In this video:
+ Viveka Roychowdhury, Editor, Express Pharma & Express Healthcare, Indian Express Group (Moderator)
+ Dr BM Rao, Head – EMQA, ASAT & CQC, Dr Reddy’s Laboratories
+ Dr PK Agarwal, Head: Analytical – Research & Technology, Hikal
+ Dr Veena Shetty, Technical Director – Analytical Development, Reliance Pharmaceuticals
+ Dr Vijaya Bharathi, VP & Head, Analytical Solutions, Aragen Life Sciences

Key Highlights:
+ Dr BM Rao, Head – EMQA, ASAT & CQC, Dr Reddy’s Laboratories:
>> Digitalisation and robotic process automation tools are improving efficiencies in analytical processes across study design, data analysis and documentation.
>> Out of specification (OOS) and out of trend (OOT) results are major challenges in analytical development. We need to optimise study design to tackle them

+ Dr Vijaya Bharathi, VP & Head, Analytical Solutions, Aragen Life Sciences
>> Continuous improvements in analytical development methods and technologies have increased their scope of application. Regulators are also encouraging adoption of new technology to improve quality

+ Dr P K Agarwal, Head: Analytical – Research & Technology, Hikal
>> Companies need to invest in skilling and training to get best results from technological advancements in analytical development.

+ Dr Veena Shetty, Technical Director – Analytical Development, Reliance Pharmaceuticals
>> It is better to build a lot of in-house capabilities in AR&D activities to gain valuable experience and best outcomes